CDKN1A and neoplasm: In this work, we have demonstrated that AM-CM treatment of hepatocarcinoma cells induces a significant increase in p53 and p21 expression and a downregulation in Mdm-2 expression, which could generate either an arrest in cell cycle or an increase in apoptosis entrance of tumor cells.